Mr. Wu joined Atom Therapeutics in August of 2019 as Senior Vice President, Global Business Development. Previously, he was our Senior Consultant in Business Development. Prior to Atom Therapeutics, Mr. Wu served as Senior Vice President, Business Development at NovaBay Pharmaceuticals Inc. (2009 - 2016), Vice President, Business Development at Genelabs Technologies Inc. (2001 to 2009), Vice President, at Kissei Pharma (USA) Inc. (1997 to 2001), Director, R&D Program Planning and Management Japan and Pacific Sector at Syntex Corporation (1989 to 1995). Areas of expertise include Product Licensing; Technology Collaboration; Alliance Management; Strategic Planning; International Marketing; New Product Planning; Global Project Management; Clinical Development. U.S. and Japan drug development experience in GI, CV, analgesic, urology, immunology and metabolic disease; Regulatory experience with FDA (USA), PMDA (Japan), NMPA/CED (China), TFDA (Taiwan), MFDS (S. Korea) for Drugs and Medical Device. Mr. Wu received his MBA, International Finance from the University of San Francisco, School of Business, and B.S. in Biology from the University of San Francisco.